Human mesenchymal stem cells are used as delivery vehicles to deliver a certain amount of TYMP activity to docifluridine, a prodrug of 5-fluorouracil, thereby converting the non-toxic prodrug docifluridine into the toxic chemotherapy drug 5-fluorouracil, thereby eliminating cancer cells. Here, TYMP is linked to cancer.